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2ABSTRACT
Rationale: Superficial erosion currently causes up to a third of acute coronary syndromes (ACS), yet we 
lack understanding of its mechanisms. Thrombi due to superficial intimal erosion characteristically 
complicate matrix-rich atheromata in regions of flow perturbation. 
Objective: This study tested in vivo the involvement of disturbed flow, and of neutrophils, hyaluronan, 
and TLR2 ligation in superficial intimal injury, a process implicated in superficial erosion.
Methods and Results: In mouse carotid arteries with established intimal lesions tailored to resemble the 
substrate of human eroded plaques, acute flow perturbation promoted downstream endothelial cell (EC)
activation, neutrophil accumulation, EC death and desquamation, and mural thrombosis. Neutrophil loss-
of-function limited these findings. TLR2 agonism activated luminal ECs, and deficiency of this innate 
immune receptor decreased intimal neutrophil adherence in regions of local flow disturbance, reducing
EC injury and local thrombosis (p<0.05).
Conclusions: These results implicate flow disturbance, neutrophils, and TLR2 signaling as mechanisms 
that contribute to superficial erosion, a cause of ACS of likely growing importance in the statin era.
Keywords: 
Superficial erosion; Endothelium; Neutrophils; Disturbed Flow; Acute coronary syndromes
Nonstandard Abbreviations and Acronyms:
ACS Acute coronary syndrome
ApoE Apolipoprotein E
CC Constrictive cuff
CXCL Chemokine (C-X-C motif) ligand
EC Endothelial cell
HA Hyaluronic acid
HSVEC Human saphena vein endothelial cell
IL-8 Interleukin-8
LCCA Left common carotid artery
MMP Metalloproteinase
MPO Myeloperoxidase
NC Non-constrictive cuff
NETs Neutrophil extracellular traps
NF-κB Nuclear factor-kappa B
PKC Protein kinase C
RCCA Right common carotid artery
SMC Smooth muscle cell
TLR2 Toll like receptor 2
VCAM-1 Vascular cell adhesion molecule 1
WSS Wall shear stress
3INTRODUCTION
Rupture of an atheromatous plaque with a thin fibrous cap has received much attention as a cause 
of ACS
1, 2
. Abundant human and experimental findings indicate that lipid-lowering, in particular statin 
treatment, mitigates this mechanism of plaque disruption
3
. Current clinical data show a shift in the 
characteristics of plaques associated with rupture (lipid and macrophage rich) concomitant with increased 
statin use, smoking cessation, and other reductions in risk factors. Human atheromata today contain less 
lipid and fewer macrophages than just a decade ago
4, 5
. But even with the best current medical and 
interventional therapy, the residual burden of recurrent events post-ACS remains unacceptable
6
. Indeed, 
ruptured thin-capped atheromata may now cause fewer ACS
7
and superficial erosion appears on the rise. 
Yet, mechanisms involved in superficial erosion have received scant attention and remain a major 
knowledge gap.
Thrombi associated with superficial erosion generally overlie fibrous rather than lipid-rich 
plaques. In contrast to plaques with ruptured fibrous caps, eroded plaques contain few macrophages but 
abundant smooth muscle cells (SMCs). In stark contrast with collagen-poor ruptured plaques, eroded 
atheromata characteristically contain abundant type III collagen
8, 9
, glycosaminoglycans, and 
proteoglycans
10
. Eroded plaques may localize preferentially in regions of low shear stress, exhibit 
impaired endothelial anti-thrombotic and atheroprotective functions
11-13
, and loss of EC
14, 15
. Markers of 
EC apoptosis increase downstream of obstructive atherosclerotic plaques in humans, sites of disturbed 
flow
16
. Oscillatory wall shear stress (WSS) favors EC death
17-19
in stenotic arteries with expanded 
intimas in rabbits, promoting thrombosis
20
. EC apoptosis activates thrombin and platelet adhesion in vitro
21, 22
as well as local EC desquamation and thrombosis in vivo
23
.
Zones of flow perturbation have high EC Toll-like receptor 2 (TLR2) expression in mouse and 
human atheromata
24, 25
, and loss of TLR2 function limits murine atherogenesis
26
. Hyaluronan (HA), a 
glycosaminoglycan prominent in human eroded plaques can ligate TLR2
10, 27
. We and others recently 
provided in vitro data supporting the involvement of TLR2 and HA in EC activation
28
associated with the 
release of the neutrophil chemoattractant IL-8 and augmented leukocyte adhesion molecules (e.g. VCAM-
1 and E-Selectin). TLR2 expression further correlates with the number of apoptotic luminal ECs in human 
plaques with characteristics of superficial erosion and with neutrophils and neutrophil extracellular traps 
(NETs)
28
. Patients with ACS due to superficial erosion (vs. rupture) have higher concentrations of 
circulating myeloperoxidase
29
, a neutrophil enzyme linked with EC death and tissue factor expression
30
.
Interaction with neutrophils alters many functions of cultured EC
28, 31
.
Thus, flow perturbation may comprise a “first hit” leading to chronic endothelial activation, 
propensity to slough, and impaired ability to repair small intimal breaches, setting the stage for an 
enhanced response to a “second hit” such as local recruitment of neutrophils, able to augment EC 
apoptosis and propagate desquamation
28
. Such unrepaired rents in the endothelial monolayer could then 
trigger platelet entrapment, activation, and thrombin generation, fostering clot formation. These 
hypotheses, derived from in vitro observations, require exploration in vivo, as cell culture experiments 
cannot fully mimic either the flow conditions or the abnormal intimal substrate associated with human 
superficial erosion.
METHODS
See online methods.
4RESULTS
Thrombi due to superficial erosion typically complicate plaques rich in hyaluronan, collagen, and 
SMC, but with scant macrophages, often located at sites of human coronary arteries surrounding stenoses, 
regions of disturbed flow. We sought clues regarding the mechanisms which might participate in 
endothelial loss in humans through study of atheromata harvested at carotid artery surgery. We used 
morphologic criteria to classify different categories of plaques from specimens in our collection with 
well-preserved intimal surfaces (Figure 1). A group of plaques with a fibrous SMC-rich and macrophage-
poor appearance was further subdivided into those with an “erosion-prone” morphology (high apoptotic 
EC content, n=7) or a “stable fibrous” morphology (low apoptotic EC content, n=10). A third group of
fibrous plaques harbored a non-obstructive mural thrombus (“eroded” morphology, n=8) (Online Figure
IA). We compared these fibrous lesions to a group of atheromata with features associated fibrous cap 
rupture: few SMC, many macrophages, and large lipid cores, (n=11). Fibrous plaques with many 
apoptotic EC or those with mural thrombi displayed much greater accumulation of neutrophils near the
luminal endothelium than those with few apoptotic EC (“stable fibrous”) or the thin-capped lipid- and 
macrophage-laden lesions (Figure 1A through D). Mural thrombi contained abundant neutrophils 
(CD66b
+
and neutrophil elastase [NE]
+
, Figure 1C and D) as previously described
32
. In the fibrous 
plaques, regions of high neutrophil content co-localized with disruption of the EC monolayer (Figure 1B 
and C). In contrast, thin-capped atheromatous lesions generally had an intact endothelial lining, and 
contained few if any neutrophils. Inspection of the deeper portions of plaques served as control for 
neutrophil content (Figure 1E). Further studies localized neutrophils in representative human atheromata
with characteristics of superficial erosion. Double staining for MPO and CD61 showed neutrophils 
(MPO
+
) adjacent to but separate from platelets (CD61
+
). MPO/NE staining colocalized MPO with NE
(Online Figure IB). Thus, neutrophil accumulation appears much more abundant in human lesions with 
erosion-prone characteristics than in those with features associated with fibrous cap rupture.
Immunofluorescent staining showed a preferential accumulation of TUNEL
+
cells in the intima, often co-
localizing with CD31
+ 
ECs, in erosion-prone plaques as compared to rupture-prone plaques (Figure 1F
and Online Figure IC). Apoptotic ECs localized preferentially in the vicinity of NE
+
neutrophils (Online 
Figure IC).
This study aimed to explore experimentally in vivo the mechanisms that underlie these findings in
human plaques related to erosion vs. rupture. To this end, we first tailored arteries to harbor matrix-rich 
fibrous intimas by injury followed by healing. We then subjected these arteries with preformed fibrous 
intimal lesions to flow perturbation induced by partial stenosis. The initial injury impaired EC 
permeability at day 0, and the EC layer recovered after a 4 week healing period (Figure 2A and Online 
Figure IIA) with local neointima formation (Figure 2A right panel, and Online Figure IIB). The 
intima/wall (media + adventitia) ratio increased significantly post injury compared to uninjured left
common carotid arteries (LCCA, Online Figure IIB and S2C, p<0.01), but the media-to-wall ratio did not 
change significantly (p=0.2). Post injury, LCCAs developed an SMC-rich neointima, with few
macrophages, lacking a lipid core, and rich in HA (Figure 2A). This approach replicates key features of 
human plaques associated with superficial erosion
9
(Figure 1). Post injury, arterial extracts contained 
significantly more mRNA encoding type I and type III collagen precursors and hyaluronan synthase 2, 
and decreased type I hyaluronidase mRNA, compatible with a slant toward HA accumulation (Figure 2B). 
E-Selectin (p<0.001) and VCAM-1 (p<0.0001) expression remained elevated 4 weeks after injury, 
indicating persistent endothelial activation at these sites, as we previously observed in injured arteries in 
rabbits (Figure 2C, Online Figure IID)
33
. Human saphenous vein ECs (HSVECs) cultured on a gelatin 
substrate supplemented with various molecular weight fractions of HA showed increased EC responses to
a 5 kDa fraction of HA (Figure 2D). Furthermore, HSVECs cultured on a 5kDa HA-enriched coating
showed concentration-dependent activation (Figure 2E). Thus, regional electric injury induces SMC and 
HA-rich intimal hyperplasia, and exposure of the basal surface of EC to low molecular weight (LMW)-
HA can chronically activate EC.
5In vivo flow perturbation.
Placement of cone-shaped polyethylene cuffs around the adventitia of the LCCA modulated
downstream flow (Figure 2F through H and Supplementary video I). Placement of a non-constrictive 
control cuff did not alter the flow velocity pattern (Figure 2G, NC), but entailed the same operative 
manipulations and adventitial disturbance as the constrictive cuff (CC, Figure 2H). At peak systole (t = 
0.1 ms), computational flow dynamic (CFD) analysis after NC placement showed a low variability in the 
velocity distribution of LCCA, and unidirectional vectors along the length of the vessel (Figure 2G). In 
contrast, CC placement yielded a high variability in the velocity distribution downstream, producing 
multidirectional vectors (Online Figure IIG). The highest velocity occurred at the narrowest end of the 
cuff and recirculation zones occurred further downstream (Online Figure IIG). At peak systole, the LCCA 
with NC presented a low evenly distributed wall shear stress (WSS) profile (Online Figure IIH), whereas 
a high variability in the WSS distribution accompanied the CC placement, with increasing values 
observed along the cuff and lowest values immediately downstream (Online Figure III). Time-averaged 
WSS plots obtained at sequential locations (Online Figure IIJ) showed no significant changes along the 
carotid in NC condition or proximal to the CC (site 1). Distal to the CC mural WSS greatly increased at 
the narrowest cuff site (2), became negative with increased amplitude slightly downstream from cuff (site
3), and oscillated from positive to negative values further downstream from the cuff (site 4). These data 
show that flow restriction in carotid arteries produces oscillatory shear stress downstream, permitting
controlled and characterized experimental manipulation of local hydrodynamics in normal arteries or 
those with tailored fibrous intimal hyperplasia.
Flow perturbation promotes neutrophil recruitment and thrombus formation in previously injured 
arteries.
Mice underwent placement of CC (n=45) or a NC (n=15) on either a normal or previously injured 
LCCA (Figure 3A and B, normal, n=19; post injury, n= 52). Control animals underwent a sham procedure 
(n=11). Neither NC placement nor sham procedure altered significantly intimal leukocyte accumulation 
downstream, demonstrating that neither the cuff material nor the surgical manipulations evoked acute 
inflammation. Neutrophils (Ly6G
+
cells) did however adhere to the arterial intima distal to the CC, much 
more in previously injured than in normal LCCA (Figure 3B, p<0.001). Further experiments extended the 
histological observations by flow cytometric analysis of luminal eluates of downstream arterial segments 
from previously injured arteries: segments of arteries experiencing flow perturbation had significantly 
increased CD45
+
Ly6G
+
cells (CC, Figure 3C and D, p<0.001). Ly6C
+
monocytes also increased in the CC 
group, albeit 10 fold less than did neutrophils, illustrating the order-of-magnitude preponderance of 
neutrophils in this acute response (Figure 3C and D, p<0.05). Ly6G
+
cells lined sites of flow disturbance
in LCCA (Figure 3E, downstream, and Online Figure IVC and IVE). In contrast, upstream areas had few
leukocytes. LCCA subjected to more prolonged flow perturbation (6h) still exhibited substantial Ly6G
+
cell accumulation, although the cell number declined two fold compared to 1h (Online Figure IV, 
p<0.001). Flow disturbance caused Ly6G
+
cell accumulation for up to 3 weeks (data not shown) 
compatible with chronic intimal disturbance. The adherent cells exhibited ultrastructural characteristics of
neutrophils with segmented nuclei and plentiful cytoplasmic granules (Figure 3F). The CC groups 
displayed increased thrombus formation (Table II, p<0.05 and p<0.01), and fibrin-rich intraluminal 
thrombi in LCCAs following 1 h of flow perturbation (Figure 3G and H). Arterial segments subjected to 
flow perturbation accumulated intimal fibrinogen (Figure 3I). Moreover, circulating D-dimer, a product 
of fibrin degradation, increased in the serum of mice from CC group after 1h of flow disturbance (Figure
3J). Finally, en face observation of the LCCA showed thrombus formation downstream of stenoses 
6(Online Figure IVD). These results demonstrate that flow perturbation provokes local neutrophil and 
thrombus accumulation in arteries with fibrous intimal hyperplasia.
Flow-mediated neutrophil recruitment promotes endothelial injury.
Sites of fatal superficial erosion complicating human atheromata show EC loss and neutrophil
accumulation
28
. We therefore tested here the hypothesis that neutrophils contribute critically to loss of 
intimal EC in circumstances implicated in erosion. We examined the effect of 6h of continuous flow 
perturbation on luminal endothelium in arteries with fibrous thickened intimas (Figure 4A). In
comparison to controls, in the CC group VCAM-1 and E-Selectin protein increased in extracts of 
downstream arterial segments (Figure 4B). Flow perturbation also promoted disturbed EC barrier function 
(Figure 4C, p<0.01) and apoptosis (Figure 4D). Further immunostaining using an anti-cleaved-caspase-3 
antibody buttressed these findings (Online Figure IXB). Locally, ECs showed ultrastructural features of 
dying cells including blebbing and vacuolization (Figure 4E). Flow perturbation significantly decreased
endothelial continuity (p<0.05), altered EC morphology, and led to EC desquamation (Figure 4F and 4H, 
p<0.05). Discontinuity in the intimal endothelium correlated with the number of firmly adherent 
neutrophils (Figure 4G). Numerous neutrophils also congregated with activated EC or co-localized with 
patches of intimal denudation (Figure 4I).
Further experiments assessed the causal relationship between neutrophil presence and endothelial 
dysfunction/loss (Figure 4J). Anti-Ly6G blocking antibody treatment 24h before cuffing induced 
neutropenia (N=11). Alternatively, administration of an anti-LFA-1 blocking antibody 1h before the 
experiment aimed to reduce neutrophil recruitment. Either treatment abolished the recruitment of Ly6G
+
neutrophils in the LCCA following 1 or 6h of flow perturbation (Figure 4K). After 6h of flow 
perturbation, either anti-neutrophil treatment likewise limited endothelial permeability in the arterial 
segments subjected to disturbed flow (Figure 4L), decreased the number of luminal CD31
+
TUNEL
+ 
apoptotic EC (Figure 4M, p<0.05) and preserved endothelial continuity (Figure 4N, p<0.05). These 
results identify neutrophils as effectors of EC injury, death, and detachment under circumstances 
associated with thrombosis due to superficial erosion.
Endogenous TLR2 activates EC and promotes neutrophil chemoattraction.
Further experiments tested the hypothesis that TLR2 participates in EC activation and potentiates
neutrophil chemoattraction or leukocyte adhesion in arteries that share features of eroded human 
atheromata. HSVEC incubated with the TLR2 agonist Pam3CSK4 (Pam3) or with vehicle showed time-
dependent increases in VCAM-1, ICAM-1, E-Selectin and IL-8 (Figure 5A). Six hours after Pam3 or 
vehicle administration i.p. to Apoe
-/-
or Apoe
-/-
Tlr2
-/-
mice, luminal eluates as well as extracts of the
remaining aorta wall (intima excluded) underwent RNA isolation and QPCR analysis (Figure 5B). 
Arterial luminal eluates from Pam3-treated Apoe
-/-
mice showed significantly increased Vcam-1, E-
Selectin, Cxcl-1, Cxcl-2, and Cxcl-5 mRNAs (Figure 5C). Aortic tunica media extracts from Pam3-treated 
Apoe
-/-
mice had increased concentrations of the chemoattractants Cxcl-1, Cxcl-2 and Cxcl-5 mRNAs but 
not messages that encode the endothelial adhesion molecules Vcam-1 or E-Selectin. Pam3 did not exert 
these actions in Apoe
-/-
Tlr2
-/-
animals, indicating that these arterial responses to Pam3 depend onTLR2. 
The Bax/Bcl2 mRNA ratio also increased in these intimal extracts, implicating TLR2 in endothelial 
apoptosis in vivo (Figure 5D). Pam3 administration augmented both VCAM-1 and E-Selectin protein in
aortas isolated from Apoe
-/-
mice, but not in Apoe
-/-
Tlr2
-/-
animals (Figure 5E), and selectively activated 
luminal EC in vivo (Figure 5F). Circulating CXCL-1 also increased in Pam3-treated Apoe
-/-
but not Apoe
-
/-
Tlr2
-/-
animals (Figure 5G). Together, these results indicate that TLR2 activation leads to the
7overexpression of neutrophil chemoattractants by both EC and mesenchymal cells, while it increases EC 
expression of leukocyte adhesion molecules, and augments luminal EC apoptosis.
Testing the hypothesis that TLR2 of arterial origin participates in the recruitment of neutrophils 
used chimeric mice constructed by transplantation of either Apoe
-/-
or Apoe
-/-
Tlr2
-/-
bone marrow to 
lethally irradiated Apoe
-/-
or Apoe
-/-
Tlr2
-/-
recipients. Mice from each of the 4 groups thus generated 
(Figure 5H) received Pam3 or vehicle and underwent analysis after 6h (Figure 5I). Eluates from aortic 
luminal extracts furnished RNA for QPCR analysis (Figure 5I). As expected, Pam3-injection strongly 
activated luminal cells in mice expressing TLR2 in both intrinsic arterial and bone-marrow derived cells 
(Group 1, Figure 5J) but not in Tlr2
-/-
mice (Group 4). Animals lacking TLR2 in bone marrow-derived 
cells alone (Group 3) retained responsiveness to Pam3, to an extent comparable with mice from Group 1. 
In contrast, mice lacking TLR2 in intrinsic arterial cells, but reconstituted with bone marrow from TLR2 
sufficient animals (Group 2), showed a much lower activation than Group 1 mice. While Pam3 increased 
circulating CXCL-1 in Groups 1, 2, and 3, Group 2 showed significantly lower blood concentration of 
CXCL-1 compared to Groups 1 and 3 (Figure 5K, p<0.001). Pre-treatment with Pam3 strongly increased
TLR2 expression in luminal ECs (Online Figure VIII. Immunofluorescent colocalization by confocal 
microscopy reveals that ECs express most arterial TLR2, although adherent neutrophils and some smooth 
muscle cells also show limited positivity. A 3D reconstruction revealed that TLR2 localizes mainly on the 
basal surface of ECs in contact with the basement membrane (Supplementary video I). In contrast, the 
apical surface of EC did not containTLR2. These results demonstrate that TLR2 expressed by intrinsic 
arterial cells participates prominently in intimal cell activation and supports the hypothesis that 
endothelial TLR2 promotes neutrophil recruitment in the context of superficial erosion.
TLR2 participates in neutrophil recruitment, EC death, and dysfunction in arteries with fibrous intimal 
hyperplasia in response to flow disturbance.
Areas of disturbed arterial flow and mouse and human atheromata exhibit overexpression of 
TLR2. These observations and the ability of TLR2 ligation to activate ECs suggested the hypothesis that
TLR2 participates in the recruitment of intimal neutrophils. Eight-week-old Apoe
-/-
or Apoe
-/-
Tlr2
-/-
mice 
first underwent LCCA injury (Figure 6A). LCCA with fibrous intimal thickening in Apoe
-/-
versus Apoe
-/-
Tlr2
-/-
showed no significant differences in internal or external diameter, or in the intima-to-wall ratio 
(p=0.2, Figure 6B and C). Tlr2 deficiency in normal or previously injured arteries did not affect the 
arterial expression of the atherothrombosis-related genes evaluated (Online Figure VC). Other mice 
underwent LCCA injury followed 4 weeks later by flow perturbation (Online Figure VID). While local 
neutrophil number did not differ between groups after 1h (Online Figure VD), after 6 h the distal arterial 
segments of Apoe
-/-
Tlr2
-/-
contained significantly fewer Ly6G
+
neutrophils than Apoe
-/-
(Figure 6E, 
p<0.01). Furthermore, Apoe
-/-
Tlr2
-/-
mice showed less disruption in endothelial continuity in arterial 
segments subjected to flow perturbation (Figure 6F), as well as decreased permeability (Figure 6G). Apoe
-
/-
Tlr2
-/-
mice had reduced local thrombus formation after 1 or 6h of flow perturbation (Table II), and 
diminished circulating D-Dimer concentrations after 6h of flow perturbation (Online Figure IIIE). These 
results support the participation of TLR2 in the recruitment of neutrophils, in EC dysfunction/loss, and in 
subsequent thrombosis in the context of superficial erosion (Figure 6H).
8DISCUSSION
Superficial erosion causes arterial thrombosis, and hence ACS, without plaque rupture, as 
disclosed by post mortem examination and optical coherence tomographic imaging in intact patients.
Studies of human autopsy specimens do not permit dissection of the mechanisms that underlie this modus 
of thrombotic complication of atherosclerosis. This study extends in vivo our prior in vitro observations 
that implicated TLR2 signaling, engagement of this innate immune receptor by hyaluronan or other 
ligands, and the participation of neutrophils in aspects of superficial erosion. 
Among several processes that may contribute to superficial erosion, flow perturbation can 
promote endothelial dysfunction and death. Yet, areas subjected solely to flow perturbation seldom
develop superficial erosion, suggesting that flow disturbance alone does not suffice to trigger thrombosis.
We therefore recently proposed a “two hit” schema for the pathogenesis of superficial erosion, a 
mechanism of coronary thrombosis apparently on the rise
5, 28
. Plaques that have precipitated thrombi due 
to erosion differ distinctly from the so-called rupture-prone plaque. These differences suggest striking 
divergences in the pathological mechanisms and support the concept that plaque composition influences 
the mode of thrombotic complication. This in vivo study used an experimental approach designed to 
mimic certain characteristics of plaques that have caused thrombosis due to superficial erosion. We
created in mouse arteries expanded intimas enriched in SMC and a glycosaminoglycan-rich extracellular 
matrix with few inflammatory cells, which recapitulates some key features of the substrate associated 
with eroded plaques in humans
8, 9
. We used ApoE-deficient mice consuming a chow rather than 
atherogenic diet to avoid producing plaques overloaded with lipids and macrophage foam cells, 
characteristics of ruptured rather than eroded lesions
34
. The use of electrical injury to stimulate intimal 
expansion proved more reproducible in extensive pilot experiments than endovascular intervention. The 
resultant lesions accumulated HA, and exhibited altered HA turnover, as indicated by reciprocal changes 
in the concentrations of mRNAs that encode enzymes involved in HA production and degradation. 
Heightened expression of E-Selectin and VCAM-1 in these arteries indicated sustained chronic EC 
activation, findings concordant with our prior work on injured rabbit arteries
33
. Other studies have shown 
HA accumulation during neointimal hyperplasia in association with the migration and the proliferation of
SMC, and that intimal HA may accentuate atherosclerosis
35, 36
. In vitro, a culture substrate enriched with 
low molecular weight HA caused low-level activation of human ECs, consistent with the notion that 
intimal HA could pave the way for thrombotic complication due to superficial erosion. Prior in vitro 
studies have seldom aimed to replicate the hydrodynamic conditions that prevail downstream of arterial 
stenosis in humans. The current in vivo findings show that flow disturbance sets the stage for thrombosis, 
in arteries with fibrous intimal thickening.
Disturbed flow and low-shear stress can activate arterial ECs through NF-κB
37, 38
and also rapidly 
augment P-Selectin and IL-8 elaboration non-transcriptionally by triggering their translocation to the EC 
luminal surface
39
. Experimental stenosis in veins promotes the accumulation of neutrophils that
participate in P-Selectin-dependent initiation/amplification of thrombosis
40
. Here, arterial ECs exposed to 
flow perturbation displayed markers of activation and apoptosis acutely and developed patches of 
endothelial desquamation. Oscillatory shear stress can induce EC apoptosis through various pathways 
including p53 and protein kinase C-ζ (PKC-ζ)
18, 41
. Apoptosis could in turn exacerbate EC detachment 
and promote thrombosis.
Substantial neutrophil accumulation distal to stenosis occurred in the arteries with fibrous intimal 
expansion. Interruption of neutrophil trafficking protected EC from activation, apoptosis, and detachment. 
These observations support the local recruitment of neutrophils in eroded plaques and their role in 
9extending injury
28, 42
, whether or not these leukocytes participate in plaque formation
43
. Neutrophil 
arrival at sites of early erosion could thus amplify and propagate conditions that promote local
thrombosis, in accord with our proposed “two hit” scheme. Granulocytes can harm EC in many ways
44
, 
including by producing proteinases that sever the tethers of the ECs to the basement membrane favoring 
desquamation
45
. Neutrophils strongly activate cultured ECs, disturb their ability to adhere to the 
basement membrane, and disturb EC morphology
28, 44
. Neutrophil elastase can degrade basement 
membrane constituents
46
, enhance EC injury
47
, favor anoikis and apoptosis
48
, and concentrations of this 
enzyme increase in patients with myocardial infarction
49
. Neutrophils also contain abundant 
myeloperoxidase (MPO), an enzyme that produces hypochlorous acid, an inducer of EC apoptosis and 
tissue factor production
30
. While a subset of recruited cells after flow perturbation express MPO in this 
study, MPO does not necessarily colocalize with Ly6G
+
neutrophils. Rather, in mice, macrophages 
contain considerable MPO, an example of the discrepancy between murine and human innate immunity. 
Dying granulocytes also generate neutrophil extracellular traps (NETs), structures that can induce EC 
death and dysfunction
50, 51
. NETs could also promote EC detachment as they contain MMP-9, a 
metalloproteinase involved in the degradation of the basement membrane type IV collagen and able to 
activate endothelial pro-MMP-2
51
. We previously reported the presence of NETs and neutrophil elastase 
at the surface of human plaques resembling those implicated in superficial erosion
28
. NETs contain tissue 
factor procoagulant and can further furnish scaffolds for coronary thrombi in culprit lesions of ACS
52, 53
.
This study demonstrates in vivo that TLR2 participates in EC activation and amplifies the 
recruitment of neutrophils after flow perturbation. ECs express TLR2 that participates in experimental 
atherosclerosis. TLR2 also localizes in human atheromata with characteristics of those that have caused 
thrombosis due to erosion
28
. Previous studies showed that low molecular weight fractions of HA can 
activate TLR2 signaling through a NF-κB dependent pathway
27
. Thus, HA could act as an endogenous 
agonist of TLR2 and contribute to neutrophil recruitment in the setting of disturbed flow, as supported by 
the present findings. The use of chimeric mice indicates that TLR2 expressed by intrinsic arterial cells 
rather than leukocytes mediates the release of neutrophil chemoattractants and the production of 
endothelial adhesion molecules. In addition to TLR2, HA can also bind various receptors including CD44 
or ICAM-1. Flow perturbation could also activate alternative signaling (i.e. by integrins) that may 
synergize with constitutive TLR2 signaling driven by HA binding. Defining the roles of these and other 
potential pathways will require further study.
The lack of experimental tools in vivo for studying superficial erosion has constituted a 
considerable hindrance, and contributes to the knowledge gap in the field. The experimental approach 
used here permitted us to test hypotheses in vivo regarding the pathogenesis of superficial erosion that 
emerged from in vitro or descriptive observations made by our laboratory and others. This in vivo 
approach permitted testing of focused mechanistic hypotheses related to the pathophysiology of 
superficial erosion. The short time course of the experiments presented here represents one of several 
limitations to the ready extrapolation of our results to a human disease that plays out over decades. Yet, 
these findings furnish some early and novel insights into the mechanisms of superficial erosion, a major 
gap area in our understanding of the thrombotic complications of human atherosclerosis. This quest has 
become increasingly clinically compelling, as current therapies have made substantial inroads in reducing 
plaque rupture, and as superficial erosion has emerged as a considerable continuing contributor to residual 
risk in the current era
5, 54, 55
.
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FIGURE LEGENDS
Figure 1. Neutrophils associate with the erosion-prone plaque morphology in humans. Human 
plaques with morphologies classified as thin-capped atheromatous lesions (n=11), fibrous without mural 
thrombosis (representing erosion prone or healed or resorbing erosive thrombus) (B), or fibrous plaques 
with non-obstructive mural thrombi (C), n=25, underwent serial cross sectional analysis (x40 
magnification) for ECs/platelets (CD31), neutrophils (CD66b) and neutrophil elastase (NE), and other cell 
types (smooth muscle cells, αSMA
+
) and macrophages (CD68
+
), and thrombus (Fibrinogen). Insets show 
higher magnification (x100). CD66
+
immunostaining quantified neutrophils located either on the luminal 
surface (D) or in the deeper intima / plaque (E). High content of apoptotic cells correlates with an 
erosion-prone morphology (F). Scale bars, 300µm. Data are expressed as mean ± s.e.m. ****p<0.0001. 
Mann–Whitney U test.
Figure 2. Creation of intimal lesions for experimental probing of mechanisms related to superficial 
erosion in mice. (A) Experimental protocol showing carotid electric injury (yellow segment) performed 
at day 0 and followed in 4 weeks by completed endothelial reconstitution. Composition of the neointima 
in post-injured arteries in ECs (CD31), vascular smooth muscle cells (SMA), macrophages (Mac3), and 
hyaluronan (HA). The insets show higher magnification views for each representative image. Carotid 
lumen (star) and internal elastic laminae (arrow) are shown. ni: neointima. The arrow represents flow 
orientation. LCCA: left common carotid injury. QPCR analysis was performed on normal vs previously 
injured carotid for the expression of extracellular matrix related mRNAs (B). Data are expressed in 2
-ΔCt
to β-actin. Each dot represents data from one animal. Mann–Whitney U test. (C) Western blot and 
relative quantification showing overexpression of E-Selectin and VCAM-1 in normal vs previously-
injured arteries, n=4. Quantitative PCR on lysates from human saphenous vein ECs cultured 48h on 
native gelatin coating (untreated) vs coating enriched with hyaluronan (HA) of various molecular weights 
(D) or vs 100 or 500µg/ml of 5kDa HA-enriched coating (E). Data are expressed in 2
-ΔΔCt
to untreated 
condition,  mean ± s.e.m, n=6 per group, *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001. Paired t-
test (F,G,H) Placement of a cone-shape polyethylene cuff around the LCCA in mice and secured by a 
circumferential suture. Effect of non-constrictive control cuff (g) or constrictive cuff placement on flow 
dynamics in carotid arteries (H). Doppler-coupled ultrasonography showing velocity patterns along the 
downstream flow (left, arrow) and the velocity peak downstream of the cuff (right, arrow) measured at 
1.5 mm downstream of the cuff (arrowhead). Computational fluid dynamics using finite volume analysis 
verified the extent of flow perturbation and recirculation. Longitudinal cross-sectional simulation of the 
effect of a non-constrictive cuff (G) or a constrictive cuff (H) showing a normalized axial velocity 
contour with superimposed velocity vectors (G,H). LCCA: left common carotid artery, LCCA: left 
common carotid artery, ECA: external carotid artery, ICA: internal carotid artery, NC: non-constrictive 
cuff, CC: constrictive cuff.
Figure 3. Flow perturbation promotes neutrophil recruitment and thrombus formation. (A) 
Experimental protocol and time points studied. (B) Ly6G immunohistochemical staining of LCCA 
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downstream segments shows the recruitment of neutrophils 1h after sham procedure (Sham, upper panel, 
n=9), placement of non-constrictive cuff (NC, intermediate panel, n=14) or constrictive cuff (CC, lower 
panels, n=46) either on normal (center) or post injured arteries (right). Uninjured upstream segments are 
shown on the left. LCCA: left common carotid artery. The graph shows assessment of the number of 
adherent neutrophils to the intima. Scale bars: 30 µm (C) Flow cytometry performed on post injured 
arteries after enzymatic digestion 1h after sham procedure (top), placement of a NC (middle) or a CC 
(bottom). n=5 per group. Viable neutrophils were identified as Lin
-
CD45
+
CD11b
+
Ly6G
+
and viable 
Ly6C
high
monocytes were identified as CD45
+
CD11b
+
Ly6C
+
. (D) Flow cytometric quantification of 
neutrophils and Ly6C
high
monocyte. *p<0.05, ***p<0.001. (E) Representative en face Ly6G 
immunofluorescent staining performed on previously injured LCCA subjected to flow perturbation (n=3). 
Segment downstream from the cuff (CC) is shown in higher magnification. (F) Electron microscopic 
images show the intima of previously injured arteries after sham procedure (top) or CC placement 
(bottom). Scale bars, 2.5 nm. Immunofluorescent staining for fibrinogen (G) or Carstairs’ staining (H) 
performed on a selection of post injured LCCA that have formed intraluminal thrombus 1h after flow 
perturbation. Scale bars, 100 µm (I) Immunoblotting showing elevated fibrinogen downstream of CC. 
Normalization, β-actin. (J) Quantification by ELISA of circulating D-dimer concentrations in mice 
subjected to sham (n=4) vs flow perturbation (CC, n=19). Data are expressed as mean ± s.e.m. Mann–
Whitney U test.
Figure 4. Flow-mediated neutrophil recruitment potentiates endothelial cell dysfunction and loss. 
(A) Experimental protocol and time points studied: LCCA were subjected to injury and 4 weeks later to 
6h of flow perturbation (CC). Sham, NC or CC arteries probed for the expression of VCAM-1 and E-
Selectin by western blot (B) or for Evans blue extravasation (C). Normalization, β-actin. (D) 
Immunofluorescent staining for endothelium (CD31), apoptosis (TUNEL) and DNA (DAPI) in cross 
sections of Sham, NC, or CC arteries. Each image shows bigger magnification on the right. Arrows show 
the presence of luminal apoptotic ECs. (E) Electron microscopy image showing ECs subjected to flow 
perturbation in previously injured arteries. ec: endothelial cell, bm: basement membrane, smc: smooth 
muscle cell, iel: internal elastic laminae, v: vacuole. Scale bars, 2µm (F) Quantification of endothelial 
continuity. (G) Negative correlation between endothelial continuity and the number of adherent Ly6G
+
neutrophils (p<0.0001, R
2
=0.29). Immunohistochemical staining for CD31 (top) or en face visualization 
in immunofluorescence of EC (CD31) and DNA (DAPI) (bottom) in downstream arteries after sham 
procedure (left, n=3), placement of a non-constrictive cuff (middle, n=4) or constrictive cuff (right, n= 8). 
Scale bars: 20µm. Arrows show patches of EC denudation. Semi-quantitative assessment of endothelial 
continuity cross sections CD31 immunohistochemistry is shown in graph (right). (I) Immunofluorescent 
staining for E-Selectin, EC (CD31) and DNA (DAPI) show EC undergoing detachment (arrow), in
contact with neutrophils (arrowhead) in arteries subjected to flow perturbation (CC). (J) Experimental 
protocol and time points showing LCCA subjected to injury, followed 4 weeks later by systemic 
injections of neutralizing Ly6G antibody, LFA-1 antibody, or vehicle before flow perturbation (CC). (K) 
Ly6G staining in imunohistochemistry shows neutrophil recruitment after 1h of flow perturbation in 
LCCA subjected to flow in groups receiving vehicle, anti-ly6G, or anti-LFA1. The graph shows 
quantification of adherent neutrophils in each group, after either 1 or 6h of flow perturbation. (L) LCCA 
from group vehicle, anti-Ly6G, and anti-LFA-1 probed for endothelial permeability using Evans blue 
intravital staining after 6h of flow perturbation. (M) Immunofluorescent staining for endothelium (CD31, 
red), early apoptosis (green), and DNA (DAPI, blue) shows luminal endothelial apoptotic cells (arrows) 
in group vehicle, anti-Ly6G, or anti-LFA-1 after 6h of flow perturbation. (N) Immunofluorescent staining 
for endothelium (CD31, red), elastin auto fluorescence (green), and DNA (DAPI, blue) shows endothelial 
continuity in group vehicle, anti-Ly6G, or anti-LFA-1 after 6h of flow perturbation. Data are expressed as 
mean ± s.e.m. *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001. Mann–Whitney U test.
Figure 5. TLR2 mediates endothelial cell activation in vivo. (A) Quantitative PCR on lysates from 
human saphenous vein ECs 6, 12 or 24h after Pam3csk4 incubation, n=6 per condition. (B) 
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Experimental protocol and time points used in the study. (C,D) Quantitative PCR performed on aortic 
luminal eluates (top, green) or media-adventitia lysates (bottom, red) isolated 6h after Pam3csk4 (Pam3, 
grey bars) or vehicle (white bars) injection in either Apoe
-/-
or Apoe
-/-
Tlr2
-/-
mice, n=6 per condition. (c) 
mRNA expression of adhesion molecules and neutrophil chemoattractants. (D) mRNA expression ratio 
between Bax and BCl2. (E) Immunoblotting for VCAM-1, E-Selectin performed on aorta after Pam3 
(grey bars) or vehicle (white bars) injection in either Apoe
-/-
or Apoe
-/-
Tlr2
-/-
mice. Normalization used β-
actin. The graph shows quantification of VCAM-1 expression (below). (F) Immunofluorescent staining 
for endothelium (CD31), VCAM-1, and DNA (DAPI) in LCCA isolated from Apoe
-/-
(left) or Apoe
-/-
Tlr2
-
/-
mice (right) 6h after injection of vehicle (top) or Pam3 (bottom). The stars indicate the lumen, the 
arrows show EC overexpressing VCAM-1. The graph (right) depicts semi-quantitatively VCAM-1 
immunopositivity in luminal EC expressed as % of intima length. (G) Quantification by ELISA of 
circulating CXCL-1 levels. (H) Generation of four groups of chimeric mice and experimental protocol of 
the study (I). Quantitative PCR performed on luminal eluate (J) and quantification by ELISA of CXCL-1 
serum levels (K) isolated from mice from each group, 6h after vehicle (white bars) or Pam3 injection 
(colored bars), n=5-6 per condition. Data are expressed as mean ± s.e.m. *p<0.05, **p<0.01, 
***p<0.001 and ****p<0.0001, Pam3 vs vehicle. ## p<0.01, ### p<0.001, comparison of selected 
groups, paired t-test.
Figure 6. Flow perturbation promotes neutrophil recruitment through TLR2. (A) Experimental 
timeline. (B) H&E staining shows neointima formation after LCCA injury in Apoe
-/-
and Apoe
-/-
Tlr2
-/-
mice. ni: neointima, m: media, a: adventitia. The star indicates the lumen. (C) Morphometric analysis 
showing measurement of internal (top, left) and external diameters (bottom, left), and the ratio 
intima/wall (top, right) and media/wall (bottom, right). (D) Experimental protocol involving LCCA injury
followed by flow perturbation (CC) in Apoe
-/-
and Apoe
-/-
Tlr2
-/-
mice. (E) Ly6G immunohistochemistry 
staining of LCCA cross-sections showing the recruitment of neutrophils 1 or 6h after flow perturbation in 
Apoe
-/-
and Apoe
-/-
Tlr2
-/-
mice. The graph shows the semi-quantitative assessment of adherent neutrophils 
to the intima after 6h of flow perturbation. Scale bar: 60 µm (F) CD31 immunohistochemistry staining 
shows endothelium. The graph (right) shows assessment of endothelial continuity (G) LCCA isolated 
from Apoe
-/-
and Apoe
-/-
Tlr2
-/-
mice were probed for endothelial permeability using Evans blue intravital 
staining after 6h of flow perturbation. (H) Summary diagram of the main findings of this study. ROS: 
Reactive oxygen species. MPO: Myeloperoxidase, NETs: Neutrophils extracellular traps, Lmw-HA: Low 
molecular weight-hyaluronan. IEL: Internal elastic lamina. Data are expressed as mean ± s.e.m. *p<0.05, 
**p<0.01. Mann–Whitney U test.
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NOVELTY AND SIGNIFICANCE
What Is Known?
 Superficial erosion involves discontinuity in the intimal endothelium and thrombus formation 
without plaque rupture.
 Erosion-prone plaques have specific features and associate with the presence of neutrophils.
What New Information Does This Article Contribute?
 Validation of an in vivo approach to recapitulate aspects of superficial erosion in mice to permit 
mechanistic explorations.
 A demonstration that neutrophils contribute critically to arterial EC injury in regions of disturbed 
arterial flow.
 Establishing a role for endothelial TLR2 in local neutrophil recruitment
Post-mortem pathological studies demonstrated the loss of endothelial cells at sites of superficial erosion 
of the culprit lesions of acute coronary syndromes, yet the mechanisms that drive this process remain 
elusive. We developed a new in vivo approach in mice that involves creating a chronic intimal lesion that 
recapitulates certain features associated with superficial erosion, followed by introduction of flow 
disturbance. We found that neutrophils selectively accumulate in the lumen of carotid arteries under these 
circumstances. This neutrophil recruitment locally disrupted the endothelial layer. TLR2 loss of function 
in arterial but not in bone-marrow-derived cells blunted these effects. These findings illustrate the utility 
of a novel experimental tool to study the mechanisms of arterial thrombi in the absence of plaque rupture.
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